Benign Prostatic Hyperplasia: Diagnosis and Treatment: Clinical Practice Guideline
DIANE Publishing, 1995 - 225 pages
Developed to apply to the typical man over age 50 with symptoms of prostatism, but with no significant medical morbidities such as diabetes. Contains recommendations for patient evaluation, symptom assessment, and diagnostic tests. Intended for clinicians and other health care providers who examine and treat men with BPH or who are otherwise involved in the care of patients with BPH. 42 tables and figures.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
adverse alpha blocker analysis assessment associated balloon dilation benefits benign prostatic hyperplasia benign prostatic hypertrophy bladder clinical combined compared complications considered controlled correlation cost determine disease effects efficacy estimated et al evaluation evidence examination failure rate finasteride findings flowrate given Guideline Health higher hospital important improvement incidence incision incontinence increase indicate Internal less mean measurement Medical method mL/sec mortality normal number of patients obstruction open prostatectomy open surgery outcome panel patients percent performed placebo practice predict preferences present pressure-flow probability procedure prostate cancer Qmax range recommended renal reported require residual urine retreatment Retropubic prostatectomy risk severe sexual significant specific studies surgery surgical symptomatic symptoms Table therapy transurethral resection treated treatment treatment of benign trials TUIP TURP University urethral urinary tract urodynamic Urol Urology volume watchful waiting
Page 151 - Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 1979;51:129-34. Adar R, Critchfield GC, Eddy DM. A confidence profile analysis of the results of
Page 168 - Retropubic and suprapubic prostatectomy: comparative clinical study. J Urol 1955;74:129-37. Taylor Z, Krakauer H. Mortality and reoperation following prostatectomy: outcomes in a medicare population. Urology (Suppl 1) 1991;38:27-31. Thompson IM, Ernst JJ, Gangai MP, Spence CR. Adenocarcinoma of the prostate: results of routine urological screening. J Urol 1984; 132:690-2.
Page 167 - M011er-Madsen B, Dorflinger T, N0rgaard JP, J0rgensen HS, Lundhus E: The significance of age on symptoms and urodynamic and cystoscopic findings in benign prostatic hypertrophy. Urol Res 1987; 15:355-8. Singh M, Tresidder GC, Blandy JP. The evaluation of transurethral resection for benign enlargement of the prostate. Br J Urol 1973;45:93-102. Siroky MB,
Page 32 - month, how many times did you most typically get up to urinate from the time you went to bed at night
Page 166 - Rollema HJ, van Mastrigt R. Objective analysis of prostatism: a clinical application of the computer program CLIM. Neurourol Urodyn 1991;10:71-6. Rollema HJ, van Mastrigt R, Janknegt RA. Urodynamic assessment and quantification of prostatic obstruction before and after transurethral resection of the prostate: standardization with the aid of the computer program
Page 159 - Holtgrewe HL, Valk WL. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 1962;87:450-9. Holtgrewe HL, Valk WL. Late results of transurethral prostatectomy. J Urol 1964;92:51-5.
Page 178 - of medical students, residents, and urologists, He is a Fellow of the American College of Surgeons and a
Page 168 - DB. Retropubic prostatectomy, 1947-1960: A critical evaluation. J Urol 1961;85:322-8. Stephenson WP, Chute CG, Guess HA, Schwartz S, Lieber M. Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester,